HOME >> MEDICINE >> NEWS
American Heart Association Comment On New England Journal Of Medicine Report OnCalcium Antagonist Nisoldipine (March 5 issue)

A study in the NEJM titled "The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension," finds an increased risk of fatal and non-fatal heart attacks among individuals taking the calcium antagonist nisoldipine compared to individuals taking enalapril, which is a member of a class of drugs called ACE-inhibitors.

The study provides more evidence that calcium antagonists (preferred term for calcium channel blockers) may pose risks for certain people, including those with diabetes and coronary heart disease. Past studies of short-acting calcium antagonists have also found increased risk of cardiovascular complications. It was thought that the longer-acting drugs did not pose similar risks. However, the current study used a long-acting drug.

Speaking for the American Heart Association, Joseph Izzo, M.D., says "individuals taking calcium antagonists should not panic and stop medication without consulting a physician. However, individuals with both known cardiovascular disease and diabetes may want to talk to their physicians about choosing another type of high blood pressure drug, or to use the calcium antagonist in combination with other agents that are complementary." Izzo is a member of the American Heart Association's Continuing Education Committee.

Calcium antagonists dilate (relax) constricted blood vessels and thus reduce blood pressure. However, this vasodilator action may force the heart to pump harder and may also stimulate stress hormones. This action is the opposite of beta-blockers that limit cardiac output, notes Izzo, professor of medicine and pharmacology at the State University of New York, Buffalo.

The study, by Raymond Estacio, M.D., of the Colorado Prevention Center, Denver, included 470 individuals who had high blood pressure and non-insulin dependent diabetes. The trial compared an ACE-inhibitor with a calcium antagonist in the p
'"/>

Contact: Carole Bullock
caroleb@amhrt.org
214-705-1279
American Heart Association
3-Mar-1998


Page: 1 2

Related medicine news :

1. Consumers with disabilities empowered by American Disabilities Act
2. Definition of persistent vegetative state available from American Academy of Neurology
3. African-American women with endometrial cancer have more aggressive cancer than Caucasian women
4. New colorectal cancer screening recommendations for African Americans
5. American Thoracic Society Journal news tips for March 2005 (second issue)
6. Community care tops medical care at preventing heart disease in black Americans
7. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
8. Obesity among African-American stroke survivors increases risk factors for recurrent stroke
9. Awards & fellowships at the International & American Association for Dental Research General Session
10. American Academy of Neurology presents 57th Annual Meeting in Miami Beach
11. News tips from the 2005, 54th Annual Scientific Sessions of the American College of Cardiology

Post Your Comments:
(Date:8/27/2014)... Time to Play Golf, a fast-growing ... , With 80-degree temperatures and only partially clouded skies, ... (TTPGolf) Inaugural Outing. Around 50 golfers showed up to duel ... beautiful Heron Glen Golf Course in Ringoes, New Jersey. , ... to be having a great time. Birdies were dropping and ...
(Date:8/27/2014)... PCOS (Polycystic Ovarian Syndrome) affects an estimated 1 ... a number of health disorders and medical conditions. However, ... within the medical community. Many women are suffering from ... body fat around the waist area (truncal obesity), but ... by PCOS. , Awareness is the first step to ...
(Date:8/27/2014)... August 27, 2014 The Connecticut Community for ... on September 19, 2014, from 10:00 AM – 2:00 PM ... turn out from participants across the state to show their ... front of Connecticut’s state capitol. , Recovery Walks! is a ... addiction to alcohol and other drugs as well as their ...
(Date:8/26/2014)... Recently, BambooIndustry.com, the popular online supplier of bamboo ... floorings for the online market. Along with that, ... the new items are offered at greatly discounted prices, ... will end on September 10, 2014. , At ... with low shipping costs. The company wants to offer ...
(Date:8/26/2014)... In its latest blog post, Best ... that having family close by during a stay in ... not the process is successful, is looking at 6 ... people need medication to help them overcome addiction, particularly ... triggers like anxiety and depression, many others will be ...
Breaking Medicine News(10 mins):Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:The CT Community for Addiction Recovery to Proudly Host 15th Annual Recovery Walks! 2Health News:Discounted, High Quality Bamboo Floorings Provided Online By BambooIndustry.com 2Health News:Latest Best Drug Rehabilitation Blog Post Looks at 6 Ways to Beat Addiction with Medication 2Health News:Latest Best Drug Rehabilitation Blog Post Looks at 6 Ways to Beat Addiction with Medication 3
(Date:8/26/2014)... SynCardia Systems, Inc., manufacturer of the SynCardia ... 5000 named by the business magazine Inc. ... Canada and CE approved Total Artificial Heart, which is ... transplant," says Michael P. Garippa , SynCardia,s CEO ... for patients dying from end-stage biventricular heart failure." ...
(Date:8/26/2014)... ALISO VIEJO, Calif. , Aug. 26, 2014 ... ) today announced the enrollment of the first ... the efficacy, safety and tolerability of AVP-786 for ... AVP-786 is a novel investigational drug consisting of ... dose quinidine. "There are millions of ...
(Date:8/26/2014)... and LONDON , August 26, 2014 ... FDNA Inc. ( http://www.fdna.com ) and London Medical Databases ... partnered to offer, for the first time, online access ... FDNA, developer of the Facial Dysmorphology ... collection into Face2Gene [ TM ] , ...
Breaking Medicine Technology:Inc. Magazine Ranks SynCardia Systems in Top 3rd in its 2014 Inc. 5000 List 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 6FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3
Cached News: